Fact CheckerSign in

NCT06690060Recruiting

Mind Body Intervention for Chronic Migraine Headaches

Source: ClinicalTrials.gov · Last updated 17 Mar 2026

Brief summary (registry, in English)

The goal of this exploratory study is to test a mind-body interventional approach for the treatment of chronic migraines. The main goal is to obtain feasibility information on the protocol which has been used in other similar conditions. We will also evaluate multiple measurement tools in order to optimize a follow-up pilot study evaluating the impact of the protocol on migraines.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
13 Nov 2024
Start date
15 Nov 2024
Primary completion date
Nov 2027
Lead sponsor
Beth Israel Deaconess Medical Center
Diseases
Migraine
NCT number
NCT06690060

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 15 Nov 2024 to the primary completion date, Nov 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known history or suspicion of headaches due to organic cause (e.g. cancer, sinus infection, head trauma, cerebrovascular disease)
  • Diagnosis of other chronic pain syndromes that may cloud assessments (e.g. fibromyalgia, chronic idiopathic neck pain)
  • Diagnosis of cognitive impairment or dementia
  • Active addiction disorder, e.g. cocaine or IV heroin use, that would interfere with study participation
  • Major psychiatric comorbidity (e.g., schizophrenia). Anxiety and mild-moderate depression are not considered exclusions.

Who the study is looking for

  • Adult (≥ 18 years of age)
  • Previously diagnosed with migraine headache based on ICHD-3 beta criteria 91
  • A score of ≥ 50 on the Headache Impact Test-6 self-report survey (moderate impact) 92
  • Presence of migraine headaches at least 5 days per month
  • Willing to engage in a Mind-Body intervention
  • Willing/able to participate in remote sessions

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beth Israel Deaconess Medical Center
Coordinator of this site? Confirm its status
BostonUnited StatesNot yet recruiting

This page is information, not medical advice. Discuss any trial with your doctor.